Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the burden of hypoglycemia and identify unmet need related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on OADs and/or insulin. This is an observational study which will identify patients with T2DM in an administrative claims database and will link claims data with results of patient and physician surveys concerning hypoglycemia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SU | T2DM patients with a prescription for a sulfonylurea but no insulin | ||
| Antidiabetic without SU | T2DM patients with an oral antidiabetic drug other than an SU, and no insulin | ||
| Insulin | T2DM patients using insulin, with or without other oral antidiabetics |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| prevalence of hypoglycemia and impact of hypoglycemia | October 2009-October 2010 |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Reported Outcomes of Hypoglycemia (including fear, awareness, behavioral modification and recovery from hypoglycemia) | October 2009-October 2010 | |
| Treatment adherence and modification related to hypoglycemia, including health status, glycemic control and healthcare utilization |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with T2DM will be identified from a large U.S. administrative claims database using a claims-based algorithm for T2DM. Patients and their associated physicians will be recruited via mail into the survey portion of this study. Survey results will be linked to actual patient care using the claims records.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Setareh Williams, PhD | AstraZeneca | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D007003 | Hypoglycemia |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| October 2009-October 2010 |
| D004700 | Endocrine System Diseases |